Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tonix Pharmaceuticals Holding (TNXP) Inventory Average (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Inventory Average over the past 3 years, most recently at $3.4 million for Q4 2025.

  • Quarterly results put Inventory Average at $3.4 million for Q4 2025, down 58.82% from a year ago — trailing twelve months through Dec 2025 was $3.4 million (down 58.82% YoY), and the annual figure for FY2025 was $4.7 million, up 5.52%.
  • Inventory Average for Q4 2025 was $3.4 million at Tonix Pharmaceuticals Holding, down from $5.9 million in the prior quarter.
  • Over the last five years, Inventory Average for TNXP hit a ceiling of $13.5 million in Q3 2023 and a floor of $3.4 million in Q4 2025.
  • Median Inventory Average over the past 3 years was $7.6 million (2024), compared with a mean of $7.9 million.
  • Peak annual rise in Inventory Average hit 28.45% in 2025, while the deepest fall reached 58.82% in 2025.
  • Tonix Pharmaceuticals Holding's Inventory Average stood at $6.9 million in 2023, then increased by 18.01% to $8.2 million in 2024, then tumbled by 58.82% to $3.4 million in 2025.
  • The last three reported values for Inventory Average were $3.4 million (Q4 2025), $5.9 million (Q3 2025), and $7.1 million (Q2 2025) per Business Quant data.